Skander Kedous
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Skander Kedous has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
Mohamed Dhaha
ENT Head & Neck Surgery Department, Salah Azaiz Institute, Tunis
3 shared publications- Alia Methnani
Department of Otorhinolaryngology, Salah Azaiz Institute, Tunis, Tunisia, Tunisia
2 shared publications - Ameni Amri
ENT Head and Neck Surgery Department, Salah Azaiz Institute, Tunis, Tunisia
2 shared publications Amira Gallas
Plastic and Reconstructive Surgery Department, Salah Azaiz Institute, Tunis
2 shared publications- Antonino Maniaci
Department of Medicine and Surgery, University of Enna “Kore”, Enna, Italy
2 shared publications - Carlos Miguel Chiesa Estomba
Department of Otorhinolaryngology Biodonostia Research Institute, Osakidetza, Donostia University Hospital San Sebastian Spain
2 shared publications
Latest Publications
- 21 August 2026
- Published by Wiley in Head & Neck
- Vol. 48 (11) , 2953-2976
Pharyngocutaneous Fistula After Total Laryngectomy: IFOS Consensus on Prevention, Diagnosis, and Management
Importance: Significant international variations exist for prevention methods, diagnostic, and management criteria for pharyngocutaneous fistula. Objective: To formulate best practice management guidelines for pharyngocutaneous fistula after total laryngectomy. Design: Modified Delphi consensus study conducted between January 2024 and November 2025 using two rounds of a structured survey. Levels of consensus were evaluated through a 9‐point Likert scale and predefined cutoffs: strong consensus (≥ 80% in 7–9 range, median ≥ 9), consensus (≥ 80% in 7–9 range, median 8–9), near‐consensus (≥ 70% in 7–9 range), or no‐consensus (< 70% agreement). Setting: International multicenter study. Participation of experts from 18 countries of America, Europe, Asia, South America, and Oceania, under the guidance of the International Federation of Oto‐rhino‐laryngological Societies (IFOS). Participants: A multidisciplinary international panel of 36 experts in head and neck surgery, otolaryngology, radiation oncology, radiology, and plastic surgery. The panelists were chosen for their clinical expertise in the area of total laryngectomy and pharyngocutaneous fistula management; published work in the form of peer‐reviewed publications, as well as geographical representation. Main Outcomes and Measures: The level of consensus in 59 statements regarding fistula definition and classification, preoperative risk factors, prevention strategies, diagnostic modalities, conservative management protocols, surgical intervention criteria, nutritional support, and patient outcomes. Results: A consensus or strong consensus was reached on 30 of 59 statements (50.8%). Strong consensus levels were reached for preoperative nutrition optimization (median 9.0), postoperative enteral feeding support (median 9.0), standardized surveillance protocols (median 9.0), and revision surgery for persisting fistulae (median 9.0). Consensus was also achieved for the use of vascularized tissue reinforcement in selected high‐risk settings, although the preferred reconstructive strategy varied according to flap type and clinical scenario. Of the 29 statements, 5 (8.5%) were excluded at Round 1 as a result of conceptual repetition as highlighted by panel feedback, and 24 (40.7%) did not reach consensus after both rounds, including fistula classification systems, prophylactic salivary bypass tubes, time to resume oral feeding postoperatively and negative pressure wound therapy. Conclusions and Relevance: This Delphi study from an international panel provides areas of agreement and ongoing equipoise across the prevention, diagnosis, and management of PCF, while demonstrating significant practice variability in terms of their classification, the use of prophylactic interventions, and conservative therapies.
- 21 August 2026
- Published by Wiley in Head & Neck
- Vol. 48 (11) , 2953-2976
Pharyngocutaneous Fistula After Total Laryngectomy: IFOS Consensus on Prevention, Diagnosis, and Management
Importance: Significant international variations exist for prevention methods, diagnostic, and management criteria for pharyngocutaneous fistula. Objective: To formulate best practice management guidelines for pharyngocutaneous fistula after total laryngectomy. Design: Modified Delphi consensus study conducted between January 2024 and November 2025 using two rounds of a structured survey. Levels of consensus were evaluated through a 9‐point Likert scale and predefined cutoffs: strong consensus (≥ 80% in 7–9 range, median ≥ 9), consensus (≥ 80% in 7–9 range, median 8–9), near‐consensus (≥ 70% in 7–9 range), or no‐consensus (< 70% agreement). Setting: International multicenter study. Participation of experts from 18 countries of America, Europe, Asia, South America, and Oceania, under the guidance of the International Federation of Oto‐rhino‐laryngological Societies (IFOS). Participants: A multidisciplinary international panel of 36 experts in head and neck surgery, otolaryngology, radiation oncology, radiology, and plastic surgery. The panelists were chosen for their clinical expertise in the area of total laryngectomy and pharyngocutaneous fistula management; published work in the form of peer‐reviewed publications, as well as geographical representation. Main Outcomes and Measures: The level of consensus in 59 statements regarding fistula definition and classification, preoperative risk factors, prevention strategies, diagnostic modalities, conservative management protocols, surgical intervention criteria, nutritional support, and patient outcomes. Results: A consensus or strong consensus was reached on 30 of 59 statements (50.8%). Strong consensus levels were reached for preoperative nutrition optimization (median 9.0), postoperative enteral feeding support (median 9.0), standardized surveillance protocols (median 9.0), and revision surgery for persisting fistulae (median 9.0). Consensus was also achieved for the use of vascularized tissue reinforcement in selected high‐risk settings, although the preferred reconstructive strategy varied according to flap type and clinical scenario. Of the 29 statements, 5 (8.5%) were excluded at Round 1 as a result of conceptual repetition as highlighted by panel feedback, and 24 (40.7%) did not reach consensus after both rounds, including fistula classification systems, prophylactic salivary bypass tubes, time to resume oral feeding postoperatively and negative pressure wound therapy. Conclusions and Relevance: This Delphi study from an international panel provides areas of agreement and ongoing equipoise across the prevention, diagnosis, and management of PCF, while demonstrating significant practice variability in terms of their classification, the use of prophylactic interventions, and conservative therapies.
- Open Access
- 23 June 2026
- Published by MDPI AG in Epidemiologia
- Vol. 7 (4) , 88
Socioeconomic Impact, Equity, and Sustainability in Head and Neck Cancer Surgery: A Structured Narrative Review
Background: Sustainable head and neck cancer (HNC) surgery is challenged by environmental impact, workforce shortages, inequitable access to advanced techniques, and policy constraints. Addressing these areas is critical for equitable, high-quality care. Methods: This structured narrative review synthesizes evidence on environmental sustainability, workforce development, technological innovation, health policy, and socioeconomic determinants in HNC surgery, without aiming to provide a systematic or exhaustive evidence synthesis. Sources included peer-reviewed literature, global workforce surveys, and international policy reports, with a focus on disparities between high-income countries (HICs) and low- and middle-income countries (LMICs). Results: Operating rooms produce up to 70% of hospital solid waste and consume 3–6 times more energy than other units; reusable instruments and improved waste segregation can reduce carbon footprints by over 50%. Workforce shortages are severe in LMICs, where subspecialty training is scarce; global partnerships, bidirectional education, and simulation-based learning can expand local capacity. Telemedicine, artificial intelligence, and three-dimensional printing enhance surgical planning, training, and access but may widen disparities without equitable deployment. Policy tools—including diagnosis-related groups, bundled payments, and universal coverage—affect access and innovation uptake. Pandemic preparedness underscores the value of resilient systems with flexible staffing and telehealth integration. Conclusions: HNC surgery requires coordinated action across environmental, workforce, technological, socioeconomic, and policy domains; however, future systematic reviews are needed to comprehensively map the evidence base and assess its methodological quality. Embedding sustainability in clinical practice, ensuring equitable innovation access, and aligning reimbursement with high-value care can strengthen system resilience, improve outcomes, and support long-term surgical service viability.
- 23 June 2026
- Published by MDPI AG in Epidemiologia
- Vol. 7 (4) , 88
Open AccessSocioeconomic Impact, Equity, and Sustainability in Head and Neck Cancer Surgery: A Structured Narrative Review
Background: Sustainable head and neck cancer (HNC) surgery is challenged by environmental impact, workforce shortages, inequitable access to advanced techniques, and policy constraints. Addressing these areas is critical for equitable, high-quality care. Methods: This structured narrative review synthesizes evidence on environmental sustainability, workforce development, technological innovation, health policy, and socioeconomic determinants in HNC surgery, without aiming to provide a systematic or exhaustive evidence synthesis. Sources included peer-reviewed literature, global workforce surveys, and international policy reports, with a focus on disparities between high-income countries (HICs) and low- and middle-income countries (LMICs). Results: Operating rooms produce up to 70% of hospital solid waste and consume 3–6 times more energy than other units; reusable instruments and improved waste segregation can reduce carbon footprints by over 50%. Workforce shortages are severe in LMICs, where subspecialty training is scarce; global partnerships, bidirectional education, and simulation-based learning can expand local capacity. Telemedicine, artificial intelligence, and three-dimensional printing enhance surgical planning, training, and access but may widen disparities without equitable deployment. Policy tools—including diagnosis-related groups, bundled payments, and universal coverage—affect access and innovation uptake. Pandemic preparedness underscores the value of resilient systems with flexible staffing and telehealth integration. Conclusions: HNC surgery requires coordinated action across environmental, workforce, technological, socioeconomic, and policy domains; however, future systematic reviews are needed to comprehensively map the evidence base and assess its methodological quality. Embedding sustainability in clinical practice, ensuring equitable innovation access, and aligning reimbursement with high-value care can strengthen system resilience, improve outcomes, and support long-term surgical service viability.
- Open Access
- 20 October 2025
- Published by Korean Cleft Palate-Craniofacial Association in Archives of Craniofacial Surgery
- Vol. 26 (5) , 202-206
Giant cell tumor of the temporal bone: two case reports and literature review
Giant cell tumor (GCT) of bone is a benign tumor originating from undifferentiated mesenchymal cells of the bone marrow. It most commonly arises in the epiphyseal regions of long bones. The skull represents an extremely rare location for GCT. Certain radiologic features involving the temporal or sphenoid bone strongly suggest this diagnosis. Skull GCT is a locally aggressive condition, posing surgical challenges and exposing the patient to a considerable risk of recurrence. In this article, we describe the diagnosis and surgical management of two patients with GCT of the temporal bone. The first patient is a 24-year-old man who presented with progressive left temporal swelling and hearing loss. Computed tomography revealed a 5.6× 4.6× 4.2 cm osteolytic lesion of the left temporal bone. The patient underwent neartotal resection and exhibited no recurrence after 10 years of follow-up. The second patient was a 55-year-old man presenting with gradual hearing loss in the right ear and trismus. Computed tomography showed a 4.7× 4.2× 3 cm temporo-sphenoidal erosive lesion. Complete surgical resection was performed with a favorable outcome and no recurrence.
- 20 October 2025
- Published by Korean Cleft Palate-Craniofacial Association in Archives of Craniofacial Surgery
- Vol. 26 (5) , 202-206
Open AccessGiant cell tumor of the temporal bone: two case reports and literature review
Giant cell tumor (GCT) of bone is a benign tumor originating from undifferentiated mesenchymal cells of the bone marrow. It most commonly arises in the epiphyseal regions of long bones. The skull represents an extremely rare location for GCT. Certain radiologic features involving the temporal or sphenoid bone strongly suggest this diagnosis. Skull GCT is a locally aggressive condition, posing surgical challenges and exposing the patient to a considerable risk of recurrence. In this article, we describe the diagnosis and surgical management of two patients with GCT of the temporal bone. The first patient is a 24-year-old man who presented with progressive left temporal swelling and hearing loss. Computed tomography revealed a 5.6× 4.6× 4.2 cm osteolytic lesion of the left temporal bone. The patient underwent neartotal resection and exhibited no recurrence after 10 years of follow-up. The second patient was a 55-year-old man presenting with gradual hearing loss in the right ear and trismus. Computed tomography showed a 4.7× 4.2× 3 cm temporo-sphenoidal erosive lesion. Complete surgical resection was performed with a favorable outcome and no recurrence.
- Open Access
- 13 August 2025
- Published by F1000 Research Ltd in F1000Research
- Vol. 14, 786
Radiation therapy for synchronous oligometastatic Nasopharyngeal cancer in a low-middle-income country
Introduction Nasopharyngeal cancer, prevalent in Tunisia, is often diagnosed at an advanced stage. The therapeutic approach for metastatic forms has evolved with the concept of oligometastasis. Our study aims to evaluate the effectiveness of curative locoregional radiotherapy in these cases, with the objectives of estimating overall and progression-free survival and identifying prognostic factors. Methods This was a retrospective study, including 50 patients treated with curative radiotherapy for oligometastatic nasopharyngeal cancer from January 1st, 2015, to December 31, 2021, at the Salah Azaiez Institute. Results The mean age was 49.6 years, with a male predominance (72%). Initial symptoms were mainly rhinological (38%) and cervical lymphadenopathy (34%). Most patients presented with an advanced stage (T3-T4: 60%, N3: 52%). Metastases were most often osseous (46%), pulmonary (38%), or visceral (liver, extra-cervical lymph nodes: 16%). Thirty-six percent of patients had a single metastatic site, while 30% had more than two. All patients received platinum-based chemotherapy (3 cycles on average), followed by locoregional radiotherapy (70 Gy in 33-35 fractions), mainly with IMRT (76%). Concomitant chemotherapy was associated in 98% of cases. These treatments were associated with adverse effects, including radiodermatitis (100%) and mucositis (98%, including 18% grade 3). Twenty-four percent of patients received maintenance chemotherapy with capecitabine, and 44% received local treatment of metastases. At 3 years, progression-free survival (PFS) was 18% and overall survival (OS) was 44%. Univariate analysis showed a significant impact of several factors on PFS (gender, T stage, interruption of radiotherapy, maintenance chemotherapy). Multivariate analysis did not identify any independent prognostic factor for PFS. However, for OS, T stage (p = 0.024) and metastatic site (p = 0.001) emerged as independent prognostic factors. Conclusion This study served to evaluate radiotherapy practices; it would be even more interesting to conduct a larger-scale study.
- 13 August 2025
- Published by F1000 Research Ltd in F1000Research
- Vol. 14, 786
Open AccessRadiation therapy for synchronous oligometastatic Nasopharyngeal cancer in a low-middle-income country
Introduction Nasopharyngeal cancer, prevalent in Tunisia, is often diagnosed at an advanced stage. The therapeutic approach for metastatic forms has evolved with the concept of oligometastasis. Our study aims to evaluate the effectiveness of curative locoregional radiotherapy in these cases, with the objectives of estimating overall and progression-free survival and identifying prognostic factors. Methods This was a retrospective study, including 50 patients treated with curative radiotherapy for oligometastatic nasopharyngeal cancer from January 1st, 2015, to December 31, 2021, at the Salah Azaiez Institute. Results The mean age was 49.6 years, with a male predominance (72%). Initial symptoms were mainly rhinological (38%) and cervical lymphadenopathy (34%). Most patients presented with an advanced stage (T3-T4: 60%, N3: 52%). Metastases were most often osseous (46%), pulmonary (38%), or visceral (liver, extra-cervical lymph nodes: 16%). Thirty-six percent of patients had a single metastatic site, while 30% had more than two. All patients received platinum-based chemotherapy (3 cycles on average), followed by locoregional radiotherapy (70 Gy in 33-35 fractions), mainly with IMRT (76%). Concomitant chemotherapy was associated in 98% of cases. These treatments were associated with adverse effects, including radiodermatitis (100%) and mucositis (98%, including 18% grade 3). Twenty-four percent of patients received maintenance chemotherapy with capecitabine, and 44% received local treatment of metastases. At 3 years, progression-free survival (PFS) was 18% and overall survival (OS) was 44%. Univariate analysis showed a significant impact of several factors on PFS (gender, T stage, interruption of radiotherapy, maintenance chemotherapy). Multivariate analysis did not identify any independent prognostic factor for PFS. However, for OS, T stage (p = 0.024) and metastatic site (p = 0.001) emerged as independent prognostic factors. Conclusion This study served to evaluate radiotherapy practices; it would be even more interesting to conduct a larger-scale study.
- Open Access
- 12 May 2025
- Published by F1000 Research Ltd in F1000Research
- Vol. 14, 294
Head and neck dermatofibrosarcoma protuberans: Case series of extensive resections and reconstructions with literature review
Dermatofibrosarcoma protuberans is a rare, locally aggressive soft-tissue sarcoma. Head and neck involvement accounts for only 10–15% of cases. Achieving clear margins in this region is challenging owing to anatomical constraints. Such cases often require extensive resection and complex reconstructions. This study presents a case series of extensive dermatofibrosarcoma resections in the head and neck, focusing on the surgical margins, reconstruction strategies, recurrence rates, and adjuvant therapy. We report four cases of head and neck dermatofibrosarcoma involving the cheek and scalp. Surgery included wide local excision with margins of 3–5 cm, which was confirmed intraoperatively by frozen section analysis. Reconstruction involved free flaps, local flaps, and healing with secondary intention. The choice depends on the defect size and location. Adjuvant radiotherapy was administered to selected cases. All patients achieved negative margins. One patient developed flap necrosis that required revision surgery. No local recurrence was observed during the follow-up (1–7 years). Head and neck dermatofibrosarcoma justifies aggressive surgical resection to achieve clear margins, which is the key to reducing the risk of recurrence. Free flaps and local reconstruction techniques ensure good functional and aesthetic outcomes. Adjuvant radiotherapy is indicated in patients with close margins or deep invasion. Long-term follow-up is essential owing to its high recurrence potential.
- 12 May 2025
- Published by F1000 Research Ltd in F1000Research
- Vol. 14, 294
Open AccessHead and neck dermatofibrosarcoma protuberans: Case series of extensive resections and reconstructions with literature review
Dermatofibrosarcoma protuberans is a rare, locally aggressive soft-tissue sarcoma. Head and neck involvement accounts for only 10–15% of cases. Achieving clear margins in this region is challenging owing to anatomical constraints. Such cases often require extensive resection and complex reconstructions. This study presents a case series of extensive dermatofibrosarcoma resections in the head and neck, focusing on the surgical margins, reconstruction strategies, recurrence rates, and adjuvant therapy. We report four cases of head and neck dermatofibrosarcoma involving the cheek and scalp. Surgery included wide local excision with margins of 3–5 cm, which was confirmed intraoperatively by frozen section analysis. Reconstruction involved free flaps, local flaps, and healing with secondary intention. The choice depends on the defect size and location. Adjuvant radiotherapy was administered to selected cases. All patients achieved negative margins. One patient developed flap necrosis that required revision surgery. No local recurrence was observed during the follow-up (1–7 years). Head and neck dermatofibrosarcoma justifies aggressive surgical resection to achieve clear margins, which is the key to reducing the risk of recurrence. Free flaps and local reconstruction techniques ensure good functional and aesthetic outcomes. Adjuvant radiotherapy is indicated in patients with close margins or deep invasion. Long-term follow-up is essential owing to its high recurrence potential.
- Open Access
- 14 March 2025
- Published by F1000 Research Ltd in F1000Research
- Vol. 14, 294
Head and neck dermatofibrosarcoma protuberans: Case series of extensive resections and reconstructions with literature review
Dermatofibrosarcoma protuberans is a rare, locally aggressive soft-tissue sarcoma. Head and neck involvement accounts for only 10–15% of cases. Achieving clear margins in this region is challenging owing to anatomical constraints. Such cases often require extensive resection and complex reconstructions. This study presents a case series of extensive dermatofibrosarcoma resections in the head and neck, focusing on the surgical margins, reconstruction strategies, recurrence rates, and adjuvant therapy. We report four cases of head and neck dermatofibrosarcoma involving the cheek and scalp. Surgery included wide local excision with margins of 3–5 cm, which was confirmed intraoperatively by frozen section analysis. Reconstruction involved free flaps, local flaps, and healing with secondary intention. The choice depends on the defect size and location. Adjuvant radiotherapy was administered to selected cases. All patients achieved negative margins. One patient developed flap necrosis that required revision surgery. No local recurrence was observed during the follow-up (1–7 years). Head and neck dermatofibrosarcoma justifies aggressive surgical resection to achieve clear margins, which is the key to reducing the risk of recurrence. Free flaps and local reconstruction techniques ensure good functional and aesthetic outcomes. Adjuvant radiotherapy is indicated in patients with close margins or deep invasion. Long-term follow-up is essential owing to its high recurrence potential.
- 14 March 2025
- Published by F1000 Research Ltd in F1000Research
- Vol. 14, 294
Open AccessHead and neck dermatofibrosarcoma protuberans: Case series of extensive resections and reconstructions with literature review
Dermatofibrosarcoma protuberans is a rare, locally aggressive soft-tissue sarcoma. Head and neck involvement accounts for only 10–15% of cases. Achieving clear margins in this region is challenging owing to anatomical constraints. Such cases often require extensive resection and complex reconstructions. This study presents a case series of extensive dermatofibrosarcoma resections in the head and neck, focusing on the surgical margins, reconstruction strategies, recurrence rates, and adjuvant therapy. We report four cases of head and neck dermatofibrosarcoma involving the cheek and scalp. Surgery included wide local excision with margins of 3–5 cm, which was confirmed intraoperatively by frozen section analysis. Reconstruction involved free flaps, local flaps, and healing with secondary intention. The choice depends on the defect size and location. Adjuvant radiotherapy was administered to selected cases. All patients achieved negative margins. One patient developed flap necrosis that required revision surgery. No local recurrence was observed during the follow-up (1–7 years). Head and neck dermatofibrosarcoma justifies aggressive surgical resection to achieve clear margins, which is the key to reducing the risk of recurrence. Free flaps and local reconstruction techniques ensure good functional and aesthetic outcomes. Adjuvant radiotherapy is indicated in patients with close margins or deep invasion. Long-term follow-up is essential owing to its high recurrence potential.
- Open Access
- 31 July 2024
- Published by Springer Nature in The Egyptian Journal of Otolaryngology
- Vol. 40 (1) , 1-5
Reconstruction of oncologic nasal defects using the forehead flap: technical aspects and results
Introduction: Skin cancer frequently hits the nasal pyramid. Reconstruction of the nasal defects of the nasal pyramid after oncologic resection is challenging for plastic surgeons due to the anatomic complexity of the nose. The forehead flap is a pedicled flap used since antiquity in the reconstruction of nasal defects. Methods: We retrospectively reviewed the medical records of 30 patients operated for skin cancer of the nasal pyramid with reconstruction of the skin defect by forehead flap between the years 2008 and 2020. Results: The mean age was 66.3. The sex ratio was 2.75. The tumor mean size of the tumor was 34 mm ranging between 19 and 50 mm. Twenty-nine patients required a second time surgery for flap severing and degreasing. The paramedian forehead flap was used in 20 cases, the “sea gull” flap in 5 cases, the inclined FF in 4 cases, and the island FF in 1 case. Conclusion: Surgical techniques of FF offer good aesthetic results with a lesser morbidity rate. Our retrospective report attests to the reliability of FF as the workhorse for the reconstruction of small and average nasal defects.
- 31 July 2024
- Published by Springer Nature in The Egyptian Journal of Otolaryngology
- Vol. 40 (1) , 1-5
Open AccessReconstruction of oncologic nasal defects using the forehead flap: technical aspects and results
Introduction: Skin cancer frequently hits the nasal pyramid. Reconstruction of the nasal defects of the nasal pyramid after oncologic resection is challenging for plastic surgeons due to the anatomic complexity of the nose. The forehead flap is a pedicled flap used since antiquity in the reconstruction of nasal defects. Methods: We retrospectively reviewed the medical records of 30 patients operated for skin cancer of the nasal pyramid with reconstruction of the skin defect by forehead flap between the years 2008 and 2020. Results: The mean age was 66.3. The sex ratio was 2.75. The tumor mean size of the tumor was 34 mm ranging between 19 and 50 mm. Twenty-nine patients required a second time surgery for flap severing and degreasing. The paramedian forehead flap was used in 20 cases, the “sea gull” flap in 5 cases, the inclined FF in 4 cases, and the island FF in 1 case. Conclusion: Surgical techniques of FF offer good aesthetic results with a lesser morbidity rate. Our retrospective report attests to the reliability of FF as the workhorse for the reconstruction of small and average nasal defects.
- 1 January 2019
- Vol. 97, 978-983
Oncologic outcomes of early glottic cancers with anterior commissure involvement treated with advanced laser cordectomies.
The contribution of transoral laser microsurgery (TLM) in the management of early glottic cancer is now well established. The anterior commissure (AC) is a delicate anatomic subsite due to its difficult access and the high risk of tumour spread from this site to the thyroid cartilage, the subglottis and the pre epiglottic space. These reasons make the endoscopic approach controversial in case of AC involvement. This is a single centre retrospective study performed between the years 2012 and 2015. Eighteen patients treated with advanced Va laser cordectomies were included. All tumours were staged T1 (78% were T1a and 12% T1b). After laser surgery 4 patients (22.22%) had positive margins. These patients were candidate to second look procedure allowing detection and treatment of residual disease. Oncologic outcomes were studied. Two patients experienced local relapses within a mean delay of 7 months. The local control rate was 88.9% while the local control using laser only was 83.33%. One patient underwent a total laryngectomy (TL) followed by adjuvant radiation therapy (RT) after a massive recurrence in the AC with infiltration of the thyroid cartilage. The laryngeal preservation rate was 94.44%. The 3 years overall survival rate reached 100% while the 3 years disease free survival was 88.9%. the TLM offers acceptable oncologic outcomes in the treatment of T1 laryngeal cancer with AC involvement.
- 1 January 2019
- Vol. 97, 978-983
Oncologic outcomes of early glottic cancers with anterior commissure involvement treated with advanced laser cordectomies.
The contribution of transoral laser microsurgery (TLM) in the management of early glottic cancer is now well established. The anterior commissure (AC) is a delicate anatomic subsite due to its difficult access and the high risk of tumour spread from this site to the thyroid cartilage, the subglottis and the pre epiglottic space. These reasons make the endoscopic approach controversial in case of AC involvement. This is a single centre retrospective study performed between the years 2012 and 2015. Eighteen patients treated with advanced Va laser cordectomies were included. All tumours were staged T1 (78% were T1a and 12% T1b). After laser surgery 4 patients (22.22%) had positive margins. These patients were candidate to second look procedure allowing detection and treatment of residual disease. Oncologic outcomes were studied. Two patients experienced local relapses within a mean delay of 7 months. The local control rate was 88.9% while the local control using laser only was 83.33%. One patient underwent a total laryngectomy (TL) followed by adjuvant radiation therapy (RT) after a massive recurrence in the AC with infiltration of the thyroid cartilage. The laryngeal preservation rate was 94.44%. The 3 years overall survival rate reached 100% while the 3 years disease free survival was 88.9%. the TLM offers acceptable oncologic outcomes in the treatment of T1 laryngeal cancer with AC involvement.